PepGen (PEPG) Stock Price

PepGen Price

NASDAQ·CLOSED
4.19
​
Market closed

The consensus 12-month price target for PepGen is 4.00 USD, about 4.5% below where the stock trades today. Of 14 analysts, 12 rate the stock a buy — an overall Buy consensus.

PepGen stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PepGen business model & stock analysis

PepGen Inc., based in Cambridge, Massachusetts, is a biotechnology company focused on developing oligonucleotide therapies for neuromuscular and neurologic diseases. The company utilizes its enhanced delivery oligonucleotide (EDO) platform, which employs cell-penetrating peptides to enhance therapeutic delivery. Its lead candidates, PGN-EDO51 for Duchenne muscular dystrophy and PGN-EDODM1 for myotonic dystrophy type 1, are part of a pipeline targeting degenerative conditions. Listed on 6 May 2022, PepGen operates with a team of 56 employees.

Frequently asked questions about PepGen

Analysts currently set an average price target of 4.00 USD for the PepGen stock (median: 4.00 USD), implying +3.1 % versus the latest price. The consensus is based on 14 analyst ratings.

14 analysts currently rate the PepGen stock: 12 recommend buying, 1 holding and 1 selling.

Converted at the current exchange rate, the PepGen share trades at 3.81 EUR (4.19 USD).

The PepGen share (PEPG) is listed on 1 stock exchanges, including: NASDAQ (PEPG).

The revenue cannot currently be calculated for PepGen.

The expected profit of PepGen is -74.48 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of PepGen is currently -2.38. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the PepGen stock.

The P/S cannot be calculated for PepGen currently.

The Eulerpool Quality Score for PepGen is 3/10.

The ISIN of PepGen is US7133171055. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of PepGen is PEPG. The ticker symbol is used to trade PepGen shares on the stock exchange.

Fair ValueTerminal
4.06 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website pepgen.com
Currency
USD
Initial public offering
May 6, 2022
ISIN
US7133171055
Cusip
713317105
Market capitalization
288.06 M USDMicro Cap
52-Week Range
PEG
0.12
P/E ratio
P/Ee 2026
-2.38
P/Ee 2027
-2.22
P/Ee 2028
-2.23
P/Ee 2029
-2.77
P/Ee 2030
-5.74
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.95
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-54.52 %
Last updated Nov 19, 2026, 1:03 AM

PepGen Peer Group

PepGen Ticker

NASDAQ · PEPG

PepGen FIGI

PEPG:US · BBG012232618PEPG:UA · BBG016W3Y425PEPG:UC · BBG016W3Y434PEPG:UN · BBG016W3Y452PEPG:UP · BBG016W3Y461PEPG:UB · BBG016W3Y489PEPG:UM · BBG016W3Y4B5PEPG:UX · BBG016W3Y4C4PEPG:UD · BBG016W3Y4J7PEPG:UW · BBG016W3Y4L4PEPG:UF · BBG016W3Y4M3PEPG:VY · BBG016W3Y4N2

All fundamentals and in-depth analysis of PepGen

Our stock analysis for PepGen stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PepGen. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.